1US Renal Data Systen.USRDS 2008 Annual data report,national institutes of health,national institute of diabetes and digestive and kidney diseases.Bethesda MD,2008.
2Weir MR.Is Activated Vitamin D Supplementation Renoprotective? Hypertension,2008,52(2):211-212.
3Zehnder D,Bland R,Williams MC,et al.Extrarenal expression of 25-hydroxyvitamin D (3)-1 alpha-hydroxylase.J Clin Endocrinol Metab,2001,86(2):888-894.
4Christakos S,Dhawan P,Liu Y,et al.New insights into the mechanisms of vitamin D action.J Cell Biochem,2003,88(4):695-705.
5Norman AW.Minireview:Vitamin D receptor:New assignmentsfor an already busy receptor.Endocrinology,2006,147 (12):5542-5548.
6Wood C,Gonzalez EA,Martin KJ.Challenges in the therapy of secondary hyperparathyroidism.Tber Apher Dial,2005,9(1):4-8.
7Segerer S,Nelson PJ,Schlondorff D.Chemokines,chemokine receptors,and renal disease:from basic science to pathophysiologic and therapeutic studies.J Am Soc Nephrol,2000,11 (1):152-176.
8Zehnder D,Quinkler M,Eardley KS,et al.Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation.Kidney Int,2008,74(10):1343-1353.
9Viedt C,Dechend R,Fei J,et al.MCP-1 Induces Inflammatory Activation of Human Tubular Epithelial Cells:Involvement of the Transcription Factors,Nuclear Factor-κB and Activating Protein-1.J Am Soc Nephrol,2002,13(6):1534-1547.
10Tan XY,Wen XY,Liu YH.Paricalcitol Inhibits Renal Inflammarion by Promoting Vitamin D Receptor-Mediated Sequestration of NF-κB Signaling.J Am Soc Nephrol,2008,19(9):1741-1752.
7McClellan WM. Epidemiology and risk factors for chronic kidney disease. Med Clin North Am, 2005, 89: 419-445.
8Liu Y. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol, 2004, 287: F7-F16.
9Kuhlmann A, Haas CS, Gross ML, et al. 1,25 Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol, 2004, 286: F526-F533.
10Hirata M, Makibayashi K, Katsumata K, et al. 22- Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats. Nephrol Dial Transplant, 2002, 17: 2132-2137.
